Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening

Authors

  • A. B. PAYNE,

    1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders, Atlanta, GA, USA
    Search for more papers by this author
  • C. J. BEAN,

    1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders, Atlanta, GA, USA
    Search for more papers by this author
  • W. C. HOOPER,

    1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders, Atlanta, GA, USA
    Search for more papers by this author
  • C. H. MILLER

    1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders, Atlanta, GA, USA
    Search for more papers by this author

Amanda B Payne, 1600 Clifton Road, MS D02, Atlanta, GA 30333, USA.
Tel.: +1 404 639 4034; fax: +1 404 639 1638.
E-mail: bvx2@cdc.gov

Ancillary